|
|
Radioresistance and genomic alterations in head and neck squamous cell cancer: Sub‐analysis of the ProfiLER protocol
Elise Rowinski
,
Nicolas Magné
,
Jérôme Fayette
,
Elisabeth Daguenet
,
Séverine Racadot
et al.
Journal articles
hal-03461669v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial
Elise Bonnet
,
Véronique Haddad
,
Stanislas Quesada
,
Kim-Arthur Baffert
,
Audrey Lardy-Cléaud
et al.
Journal articles
hal-03915443v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial
Alice Bonneville-Levard
,
Didier Frappaz
,
Olivier Tredan
,
Emilie Lavergne
,
Véronique Corset
et al.
Journal articles
hal-03915456v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Genomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer: A Subgroup Analysis of AGO OVAR 12 Trial
Jean-David Fumet
,
Emilie Lardenois
,
Isabelle Ray-Coquard
,
Philipp Harter
,
Florence Joly
et al.
Journal articles
hal-03769697v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
EZH2 alterations in follicular lymphoma: biological and clinical correlations
Sarah Huet
,
Luc Xerri
,
Bruno Tesson
,
Sylvain Mareschal
,
Sébastien Taix
et al.
Journal articles
hal-01566524v2
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Actionable molecular alterations in advanced gynaecologic malignancies: updated results from the ProfiLER programme
Romain Varnier
,
Olivia Le Saux
,
Sylvie Chabaud
,
Gwenaëlle Garin
,
Emilie Sohier
et al.
Journal articles
hal-03487380v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Immunological and classical subtypes of oral premalignant lesions
Jean-Philippe Foy
,
Chloé Bertolus
,
Sandra Ortiz-Cuaran
,
Marie-Alexandra Albaret
,
William N Williams
et al.
Journal articles
hal-02339198v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial
Olivier Trédan
,
Qiang Wang
,
Daniel Pissaloux
,
Pierre Cassier
,
Arnaud de La Fouchardière
et al.
Journal articles
hal-02367110v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|